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Abstract:  
The aim of this study was to demonstrate the presence of the A189G age-related 
point mutation on DNA extracted from bone. For this, a PNA/DNA sequencing method 
which can determine an age threshold for the appearance of the mutation was used. 
Initially, work was done in muscle tissue in order to evaluate the sensitivity of the 
technique and afterwards in bone samples from the same individuals. This method was 
also applied to ancient bones from 6 well preserved skeletal remains. The mutation was 
invariably found in muscle, and at a rate of up to 20% in individuals over 60 years old. 
In modern bones, the mutation was detected in individuals aged 38 years old or more, at 
a rate of up to 1%, but its occurrence was not systematic (only 4 out of 10 of the 
individuals over 50 years old carried the heteroplasmy). For ancient bones, the mutation 
was also found in the oldest individuals according to osteologic markers. The study of 
this type of age-related mutation and a more complete understanding of its 
manifestation has potentially useful applications. Combined with traditional age 
markers, it could improve identification accuracy in forensic cases or in anthropological 
studies of ancient populations.   
 
Keywords: Mitochondrial DNA · Heteroplasmic point mutation ·  Ageing · Modern 
and ancient bones. 
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Introduction 
The ageing theory presented by Harman [1] and supported by Beckman and 
Ames [2] postulates that the production of free radicals rises with age, and plays a key 
role in the degenerative processes of senescence. This oxidative stress increase could 
thus be at the origin of all cellular molecule damage and in particular, could induce the 
accumulation of lesions on mitochondrial DNA (mtDNA). These lesions were found in 
numerous tissues with high metabolism, especially in post-mitotic tissues [3, 4, 5]. They 
took several forms - mostly insertions, deletions and heteroplasmic point mutations. The 
presence of this latter mutation type has never been closely studied in bone, for which 
only deletions have been highlighted [6]. However, observing the presence or absence 
of heteroplasmic mutations in bones could be useful in skeleton identification or in 
mitochondrial analysis of archaeological bones. Indeed, when heteroplasmic mutations 
are found, they could have been inherited from the mother (because of mtDNA maternal 
inheritance) or induced by oxidative stress and the lack of lesion repair. In this latter 
case, the mutations are somatic and accumulate during the natural ageing process. 
Consequently, their study might be helpful in age evaluation (e.g forensic sciences), 
where burnt or damaged bones prevent the use of traditional osteology markers. In the 
same way, it could be an important tool in anthropological studies where the detection 
of these possible age-related mutations could be used along with osteology markers and 
provide an interesting approach to determining the state of health of past populations.  
The general aim of this study was to show that mtDNA heteroplasmic point 
mutation can be linked with ageing in DNA extracted from bone. The mutation chosen 
for this was an adenine to guanine transition at position 189 (A189G).  This transition 
presents high, easily detectable heteroplasmic mutation rates in muscle tissue. Its level 
been detected at an increasing rate in muscle tissue from older individuals [4, 5, 7, 8, 9]. 
In the present study, this mutation was investigated in both muscle and bone from the 
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same individuals, thus providing a comparison of heteroplasmic variability between the 
two tissues. Heteroplasmy detection requires a very sensitive method able to detect 
mutations at low levels, hence the selection of PCR with PNA/DNA sequencing method 
which provides an age threshold for the appearance of the mutation [10, 11]. The Peptid 
Nucleic Acid (PNA) molecule is a DNA mimic, in which the negatively charged sugar–
phosphate DNA backbone is replaced by an achiral, neutral polyamide backbone 
formed by repetitive units of N-(2-aminoethyl) glycine. The PNA probe perfectly 
hybridizes to a target DNA region and prevents PCR primer binding, whereas single 
base-pair mismatches containing PNA exhibit minimal primer binding inhibition [9, 
11]. Thus, incorporating the PNA probe in the PCR reaction mixture allows preferential 
amplification of the mutated fragments and is more sensitive in detecting the mutation 
during sequencing. 
Thus the three specific objectives of this study were  
(i) to detect the mutation in the mtDNA extracted from bone tissues  
(ii) to confirm that it is a somatic mutation, to determine the age at 
appearance and its possible variations depending on the tissues under 
consideration, and then  
(iii) to show that these somatic heteroplasmy types can also be evaluated in 
bone from ancient skeletal remains. 
To this end, bone and muscle from the same individuals (called “modern samples”) as 
well as bones from archeological specimens (called “ancient bones”) were analysed. In 
addition, individuals were described as young or old at death to distinguish between the 
modern and ancient bones. 
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Materials and methods 
Samples 
Modern samples were collected during medico-legal autopsies from accidental death 
victims, secondarily identified and exempt from any specific macroscopically detectable 
diseases. The sample from each individual consisted of a sternal fragment extremity of 
the fourth rib, and a part of the associated intercostal muscle. This double sampling had 
a dual purpose: firstly, to check the exact correlation between sequences of different 
tissues from the same individual and secondly, to specifically evaluate the level of the 
189 heteroplasmy in the bones. In a laboratory dedicated to modern samples, 34 
unrelated individuals ranging in age from 1-87 years at death were thus analysed, 
including 7 individuals from whom only muscle was collected. First, the muscle was 
carefully removed from the bone with a scalpel. Then, the bones were placed in a 
microwave oven (5 x 1 min) to eliminate soft tissues [12]. The marrow remaining in the 
bone matrix was cleaned with distilled water and the bone was then crushed with a 
mortar. 
The six ancient samples dating from the 17th to the early 19th century were collected 
during excavations performed by the MAFSO (French Archaeological Mission in 
Oriental Siberia) team in 2003 and 2004 in Central Yakutia (north-eastern Siberia). The 
extremely cold, dry climate of this region generally provided a well-preserved nucleic 
acid chain [13]. Of the six specimens studied, two were identified as newborns using 
the method described by Scheuer and Black [14]. Two adults and two old adults were 
identified by the ageing process of the human skeleton as presented elsewhere [15, 16]. 
Ancient DNA samples were collected from femur, tibia, humerus and patella bones. 
The protocol to eliminate surface contamination and to generate the powdered bone 
from bone fragments is described elsewhere [17]. The ancient bones were treated with 
extreme precautions during each step of sample preparation. DNA extraction and PCR 
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amplification were carried out in a DNA laboratory specifically for ancient bones as 
described elsewhere [13, 17]. In both laboratories, the technical personnel handling 
bone material were genotyped for the neighbouring 189 mtDNA region. Extraction and 
amplification blanks were used as negative controls for both modern and ancient 
samples 
Digestion and extraction protocol 
DNA from approximately 1cm3 of muscle and bone samples were extracted with buffer 
as described in Thèves et al. [9]. The aqueous phase was purified with the Cleanmix kit 
(Talent, Trieste, Italy) and eluted in 100 µl of sterile water. DNA extracted from the 
bones was then concentrated in Microcon YM30 filters (Millipore, Billerica, MA) in 
40µl for the modern samples and 30µl for the ancient ones. 
Amplification, purification and sequencing 
For each sample, two conditions of PCR were carried out with and without a PNA 
probe using the same reaction volume as applied elsewhere [9], with additional PNA of 
8 µM final when amplifications were performed with this probe 
(CAGGCGAACATACTT). Amplification reactions were carried out in a thermocycler 
T3 (Biometra, Archamps, France) using the following steps: initial denaturation (95°C, 
10 min), 35 cycles of denaturation (95°C, 30 s), primer hybridization (60°C, 30 s), 
elongation (72°C, 1 min) and a final elongation (72°C, 7 min). PCR with PNA was 
carried out with the additional step of probe hybridization (69°C, 30 s) between the 
denaturation and primer hybridization steps. For DNA extracted from the ancient 
bones, the number of cycles was raised to 40, and probe concentrations of 2 and 8µM 
were tested, in order to obtain a sufficient quantity of PCR products before sequencing. 
All PCR products were purified with QIAquick® kit (Qiagen GmbH, Hilden, Germany). 
The sequencing reactions were performed on both forward and reverse DNA strands for 
each sample and for both conditions using the BigDye Terminator v1.1 kit (PE 
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Applied Biosystems, Courtabeuf, France). The products were purified as recommended 
by the manufacturer and submitted to an ABI Prism 310 Genetic Analyser (PE Applied 
Biosystems). The electropherograms were analysed using the Sequencing Analysis 5.2 
Software (PE Applied Biosystems). 
Southern blotting 
To confirm the results obtained after sequencing, mtDNA from ancient bones was also 
tested by Southern blotting. The amplification of PCR products from the samples and 
the chemiluminescent technique were performed under the same conditions as 
described in Thèves et al. [9]. However, the quantity of ancient DNA was increased: 40 
cycles of PCR were carried out and a total of 25 µl PCR products were blotted onto 
membranes.  
 
Results  
The sequences obtained are located between positions 133 and 252 in the HVR-
II region of mtDNA. Figure 1 shows the results obtained at position 189 with and 
without PNA on three bone samples, representing a young individual (Fig. 1a), an old 
individual from modern bones (Fig. 1b), and an old subject from ancient bones (Fig.1c). 
As described in the guidelines of Brandstätter et al [18], at position 189, the G 
nucleotide was considered heteroplasmic if a secondary peak of more than about 10% of 
the height of the primary peak was present. This was confirmed for both the forward 
and reverse sequencing reactions. 
In muscle tissues: A total of 34 DNA sequences were studied from muscles 
(Table 1). Of these sequences, 10 taken from people over 39 years of age presented a 
heteroplasmy at position 189 with conventional sequencing. After the addition of the 
probe in the PCR mixture before sequencing, only 3 of the samples did not carry the 
heteroplasmic mutation (1, 14 and 16-year-old). All remaining muscle samples showed 
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the coexistence of the two nucleotides (A/G noticed R) at position 189or only the 
presence of the G peak in the electropherogram.  
 In modern bones: Without using the probe, no heteroplasmy could be 
highlighted (Table 1), which could mean that the mutation never occurs in this tissue at 
a rate higher than 20-30 %. In fact, the sequencing technique alone detected no 
secondary peak below this threshold according to the neighboring sequence [9, 11, 19]. 
When a PNA probe was added during amplification it showed that 9 out of the 27 
individuals tested carried the heteroplasmic mutation in bones, all of whom were over 
38 years of age (Table 1). For bone from individuals over 50 years of age, the mutation 
was only present in 40 % of cases, whereas for muscle tissue the mutation was always 
found. 
 In ancient bones: No A189G heteroplasmy was detected in any of the 6 ancient 
samples analysed using the conventional sequencing technique (Table 1). On the other 
hand, the sequencing of PCR products with PNA revealed that 3 of them (YAK20, 
YAK31 and YAK32) showed a second fluorescence peak at position 189, which is 
clearly visible in Fig.1c for YAK32. In the two newborn individuals and in one of the 
two “adult” individuals, the 189R heteroplasmy was not found. These results were 
obtained with both probe concentrations (2 and 8 µM), the G peak being higher and 
more clearly identifiable for the latter PNA concentration. Since all the ancient bone 
samples were identical to CRS [20] next to the probe’s hybridization region, they could 
be analysed by Southern blotting. The 189G mutant molecules were only detected on 
two old individuals (the detection limit being 10 % with the protocol applied [9]). The 
189G mutation was not detected in subjects belonging to “newborn” and “adult” age 
classes by the Southern blot technique. 
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Discussion 
The study of adjacent polymorphisms - flanking position 189 in the 
electropherograms - confirmed that all samples were identical to the CRS sequence [20] 
next to the probe hybridization region, except for one sample from a 36-year-old 
individual (Table 1, subject identified by an asterisk). This subject presented one 
heteroplasmy (G→A) at position 185, visible by sequencing without probe in both 
tissues. Present in a young individual, this mutation was probably not somatic and was 
of no interest in the context of our study. Furthermore, this mutation did not interfere 
with the probe hybridization since the 185A mutated peak is preferentially amplified 
with the 189G peak after the addition of the PNA probe. 
In Table 1, the observation of only a G peak after additional PNA may generate 
discussion. For example, in the case of a female subject of 21 years old, the 
identification of only one G peak could be explained in two ways. Firstly: the level of 
heteroplasmy present in this subject is not known. As described in our previous study 
[9], for position 189, heteroplasmy is not detectable at level ≤ 30% for conventional 
sequencing, and the possible level of heteroplasmy could be between 0-15 % in muscle 
for subjects of 20-30 years old (see Fig. 5 in [9]). Secondly, in Hancock et al. [21], their 
Fig. 4 shows the sequence analysis of a representative A3243G sample amplified with 
no PNA or with various concentrations of PNA. They found that a PNA concentration 
of 2 µM was optimal for the greatest suppression of the wild-type 3243 mtDNA. 
Moreover the mutant 3243 is preferentially amplified and is the dominant species with 
all PNA concentrations. For 8 µM of PNA, the G mutant peak is heavily predominant, 
whereas the A wild-type peak is at a low level, and it may be identified as baseline 
noise. In the majority of the electropherograms in our study, the 189A peak is absent or 
at a low level for 8 µM of 189A PNA probe. 
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To evaluate the detection level of the PNA/DNA sequencing method, five DNA 
samples from individuals aged 1, 13, 14, 16 and 19 years old whose mutation level had 
been estimated by Real-Time PCR (qPCR) in a previous muscle study [9], were 
analysed. For the 1, 14, and 16-year-old individuals - whose rate was less than 0.3 % - 
no heteroplasmy was detected with the PNA/DNA sequencing method (Table 1). 
Above this percentage, heteroplasmy was always seen in the electropherograms. 
Considering a possible range of error inherent in the qPCR technology, the minimum 
detection threshold of heteroplasmy may be estimated at 1 % in the conditions applied 
using this PNA/DNA method. This minimum was also found in other studies which 
used the same technology [21].  
An observation can be made about the quality of the sequences generated in this 
study. For modern samples, the quantity of DNA was always sufficient to obtain high 
quality electropherograms. As in the work of Brandstätter and Parson [22], for low 
quality sequences or in the case of sequences with very high background noise, 
detecting a low level of heteroplasmy is almost impossible. This could also be a 
problem for ancient bones. PCR and sequencing with or without PNA were repeated 
two or three times to obtain a good quality sequences. It was observed that with PNA, 
the 189G peak is better individualized and there is no uncertainty in the detection of 
heteroplasmy (see Fig. 1c). However, while this PNA/DNA technique is certainly 
applicable to ancient DNA, a very large quantity is required.  
 The principal findings are that somatic 189 heteroplasmy can be visualised from 
bones and that its appearance occurs later when compared to muscle tissue. These facts 
lead to several discussion points: 
 Firstly, the difference in (a) the appearance age and (b) the heteroplasmy rate 
variability between muscle tissue and bone for each individual demonstrate that the 
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independent extraction of each tissue was properly carried out: consequently, the 
heteroplasmy found in bone DNA can only be from bone cells. 
 Secondly, this study emphasizes that tissue specificity is present within the 
same individuals for the 189 mutation. Similar cases had already been found in other 
tissues [3, 4] and for other somatic mutations [23]. In the present case, the A189G 
tissue variability (that is, the difference in both appearance age and heteroplasmy rate 
variability), could be explained by a difference in the metabolism of muscle and bone 
[24]. 
Finally, this study demonstrates for the first time, that this type of somatic point 
mutation exists in bone tissue and is linked to age. The age threshold for the appearance 
of the mutation A189G in muscle is about 20 years [9]. In addition, although the 
sample is reduced for this tissue, a later age for the appearance threshold in modern 
bone is suggested: 38 years. However, while the presence of the 189 mutation seems 
fairly well correlated with age in the muscle, it is more difficult to demonstrate a direct 
correlation in the bone. In fact, only 9 modern individuals out of 22 over 38 years old 
(or approximately 41 %) carried the heteroplasmic mutation in bone at a rate higher 
than 1 %.  
In Table 1, bone tissue was not collected from 6 of the youngest individuals. 
These samples came from a previous study in which the heteroplasmy level was 
quantified using PNA/qPCR [9]. The autopsies on these individuals were performed 
before the beginning of this current work, and the extraction of bone was not part of the 
autopsy protocol [9]. Consequently, no bone tissue samples from young subjects (less 
than 20 years old) were available for testing the occurrence of bone heteroplasmy. 
However, the 189 muscle heteroplasmy was only detected in two subjects (13 and 19 
years old) at a low level of 0.3%. So, in bones, where heteroplasmy occurs later than in 
muscle, bone heteroplasmy for these youngest subjects should, in principle, be absent. 
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These results obtained using PNA/DNA sequencing appear consistent with those 
obtained from muscle using qPCR [9]. Indeed in Thèves et al. [9], where the 
heteroplasmy rate was evaluated in 50 individuals, the mutation was present at a rate of 
5% from 20 years old and increased above this age. So in both cases (with the two 
methods), heteroplasmy was detected in individuals over 20 years of age. Therefore, the 
technique described in the present study appears to be a fast and reliable method to 
determine the presence of these somatic mutations. A multi-factorial approach 
combining this mutation detection method with other markers currently employed to 
study skeletal remains (such as bone remodeling, cranial suture synostosis, degenerative 
diseases, dental indicators) is likely to increase the reliability of age evaluation. 
For samples taken from ancient bone remains, cold conservation in permafrost 
provided a sufficient quantity of good quality DNA to analyse the position 189 in the 
ancient Yakut bones. Our study revealed that only one adult and the two oldest 
individuals carried the mutation detected using the PNA/DNA sequencing method. 
Furthermore, the fact that the 189 heteroplasmy was only detected in the oldest 
individuals, and not in the youngest, demonstrates that this mutation is not due to 
oxidation reactions which could start after the individual’s death. Actually, 
modifications of transition types could occur at death in certain sites known to have 
high mutation rates [25]. In addition, by providing new indicators for age evaluation, 
this mutation study could also be very helpful during anthropological studies. In such 
studies, the state of health of past populations could be analyzed by comparing the 
mutation appearance age with modern populations (still living in a traditional way). 
 
Outlook: The presence of the 189 mutation in bone is not systematic even in old 
individuals. The study of a single mutation is obviously not sufficient. It would be 
interesting to relate the presence of this mutation in bone tissue to other mutations 
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known to be highly polymorphic. Specifically, the mutations T408A, C150T, or others 
in a control region whose presence seems to be clearly correlated with ageing [23] could 
be studied together with the SNaPshot technology [26]. These mutation studies can also 
be applied to ancient DNA [27]. If the combination of these point mutations is not 
sufficient to obtain accurate ageing indicators, other mutations in the coding region, 
whose rate also seems to increase with age in muscle tissues, may possibly complete the 
study. More specifically, the 8344, 3243 and 10006 [23, 28] positions as well as 
modification types like mini-duplications could be also tested [29].  
 
Conclusion:  
This study demonstrates for the first time that the 189 heteroplasmy correlated 
with age in muscle, is also found in bone, despite strong tissue specificity for the 
appearance of this mutation. Furthermore, it is shown that this mutation is found in 
archaeological specimens and therefore probably in old and degraded bones studied in 
forensic cases. 
This first result should open up many research lines in the biological field, in the 
study of ageing mitochondrial DNA, and more specifically in musculo-skeletal tissue. 
Pending the discovery of new age-related mtDNA positions, determining the 189 
heteroplasmy point could be added to the current osteology markers.  Since the 
presence of this heteroplasmic mutation in bone gives a first indication of the age at 
death (38 years old or more), the position 189 on the mtDNA can be considered as an 
interesting potential marker for age estimation in forensic identification. New 
information about its presence, gathered in a common database for example, could 
permit researchers to improve its use in identification. 
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Table 1: Detection of the A189G heteroplasmy for each individual according to 
different techniques used. 
Modern samples 
 n: 34 
Muscle 
189 position 
Bone 
189 position 
Age (years) 
 
sex Simple  
Sequencing 
Sequencing 
 with PNA probe 
Simple  
Sequencing 
Sequencing 
 with PNA probe 
1 Y 189 A 189 A ns ns 
13 Y 189 A 189 R ns ns 
14 Y 189 A 189 A ns ns 
16 X 189 A 189 A ns ns 
19 Y 189 A 189 R ns ns 
21 X 189 A 189 G 189 A 189 A 
22 X 189 A 189 R 189 A 189 A 
26 X 189 A 189 R 189 A 189 A 
30 X 189 A 189 G ns ns 
30 Y 189 A 189 R 189 A 189 A 
36* Y 189 A 189 G 189 A 189 A 
38 X 189 A 189 G 189 A 189 R 
38 Y.1 189 A 189 G 189 A 189 A 
38 Y.2 189 A 189 G 189 A 189 A 
39 X.1 189 A 189 G 189 A 189 A 
39 X.2 189 R 189 G 189 A 189 A 
39 Y.1 189 A 189 G 189 A 189 R 
39 Y.2 189 A 189 G 189 A 189 R 
43 Y 189 R 189 G 189 A 189 A 
48 X 189 A 189 G 189 A 189 R 
48 X.2 189 A 189 G 189 A 189 A 
48 Y 189 R 189 G 189 A 189 R 
50 X 189 A 189 G 189 A 189 A 
54 Y 189 A 189 G 189 A 189 A 
55 X 189 A 189 G 189 A 189 R 
58 Y.1 189 R 189 G 189 A 189 A 
58 Y.2 189 R 189 G 189 A 189 A 
65 Y 189 A 189 G 189 A 189 R 
66 X 189 R 189 G ns ns 
71 Y 189 R 189 G 189 A 189 A 
73 X 189 R 189 G 189 A 189 R 
77 X 189 R 189 G 189 A 189 A 
87 X.1 189 R 189 G 189 A 189 R 
87 X.2 189 A 189 G 189 A 189 A 
Ancient samples 
n : 6  
Bone 
189 position 
YAK 30 : nb nd ns ns 189 A 189 A 
YAK 29 : nb nd ns ns 189 A 189 A 
YAK 15 : a Nd ns ns 189 A 189 A 
YAK 31 : a nd ns ns 189 A 189 R 
YAK  20 : oa nd ns ns 189 A 189 R 
YAK 32 : oa X ns ns 189 A 189 R 
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Age and sex were known in muscles and bones from modern samples.  
X: female subject; Y: male subject; ns: no bone or muscle sample; * heteroplasmy to 
185 position. 
Class of age was assigned to ancient bones. nb: newborn; a: adult; oa: old adult; nd: sex 
no determined. 
R: indicating the heteroplasmy 189 A/G. 
In modern bones, 9/23 individuals of 30 years old and over carried the mutation and 
4/10 individuals over 50 years old. In ancient bones, the heteroplasmy was found in 3 / 
4 adult subjects by sequencing with PNA probe. 
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Fig. 1 
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Legend of Figure 1: Electrophoregrams visualised after sequencing without and with 
PNA probe in bone tissues.  
The arrow indicates the 189 position. 
a: for 26 years-old individual, in both cases (without and with PNA), any heteroplasmy 
to 189 position is visible in bone. 
b: In 55 years-old subject, sequencing without PNA presents an alone 189A peak. 
However, with 8 µM of PNA probe, the 189R heteroplasmy is detected in bone. 
c: Once again, for the archaeological specimen YAK32 (old adult), the 189R 
heteroplasmy  is visible with PNA (8 µM of probe) in ancient bone. 
 
 
 
 
 
 
 
 
 
 
